Thus, our study aimed to investigate the characteristics of HER2-low breast cancer compared to HER2-0 breast cancer, particularly in hormone receptor (HR)-positive breast cancer, and analyze the long-term oncologic outcomes. The gene discussed is ERBB2; the disease is breast cancer.